VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · IEX Real-Time Price · USD
3.070
+0.110 (3.72%)
At close: Mar 28, 2024, 4:00 PM
3.470
+0.400 (13.03%)
After-hours: Mar 28, 2024, 7:46 PM EDT
VYNE Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for VYNE Therapeutics stock have an average target of 7.38, with a low estimate of 5.75 and a high estimate of 9.00. The average target predicts an increase of 140.39% from the current stock price of 3.07.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for VYNE stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5.75 | Strong Buy | Reiterates | $5.75 | +87.30% | Feb 29, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $28 → $5.75 | Strong Buy | Maintains | $28 → $5.75 | +87.30% | Oct 30, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +812.05% | Aug 14, 2023 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $5 → $9 | Buy | Maintains | $5 → $9 | +193.16% | May 12, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +812.05% | May 12, 2023 |
Financial Forecast
Revenue This Year
459.00K
from 424.00K
Increased by 8.25%
Revenue Next Year
255.00K
from 459.00K
Decreased by -44.44%
EPS This Year
-1.02
from -2.78
EPS Next Year
-0.98
from -1.02
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 525,000 | 525,000 | 525,000 | 21.5M | 105.5M |
Avg | 459,000 | 255,000 | 255,000 | 10.5M | 58.2M |
Low | 392,000 | n/a | n/a | n/a | 13.3M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 23.8% | 14.4% | 105.9% | 8,341.2% | 909.4% |
Avg | 8.3% | -44.4% | - | 4,000.0% | 456.6% |
Low | -7.5% | - | - | - | 27.5% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.05 | -1.01 | -1.10 | -10.24 | -0.16 |
Avg | -1.02 | -0.98 | -1.07 | -9.95 | -0.15 |
Low | -0.98 | -0.94 | -1.03 | -9.56 | -0.15 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.